View this email in your browser ([link removed])
[link removed]
[link removed]

Your source for the latest news in drug policy. Visit our website ([link removed]) for more news.

More worrying news on how marijuana can drive severe mental illness: A systematic review ([link removed]) published in Biomolecules in March found that “cannabinoids likely contribute to chronic psychotic events and schizophrenia, especially if taken during adolescence.” The review found that the odds ratio of developing psychosis-like events or schizophrenia was 2.88—with a twofold greater risk among teens.

The review analyzed 10 studies, all of which found that marijuana use was associated with an increased risk for schizophrenia or psychosis-like events. A shocking nine of these studies determined that the increased risk was statistically significant. The researchers noted that the “most intriguing result in our analysis is the large age effect,” pointing to the elevated risk among adolescents.

The researchers “speculate that cannabinoids have two major psychotic effects: acute psychotic sensations comparable to other hallucinogenic drugs and indicative of acute toxicity; and altered synaptic plasticity during adolescence.” These findings help explain the growing body of evidence linking marijuana use to severe mental illness.

The new data undermines a key prop of a deeply harmful belief not backed up by science: that the connection between schizophrenia and marijuana arises from sufferers using the drug to self-medicate. Wrong, notes Alison Knopf of Alcoholism & Drug Abuse Weekly ([link removed]) . “The study does much to dispense with a ‘self-medication’ hypothesis—which would hold that people with schizophrenia use marijuana to control symptoms. This ‘chicken-and-egg' conundrum may still persist, but the evidence indicates that it is the cannabis which came first in these cases.”
Received this email from a friend? Sign up here! ([link removed])
[link removed]

[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

Smart Approaches to Marijuana (SAM) ([link removed]) is an alliance of organizations and individuals dedicated to a health-first approach to marijuana policy. We are professionals working in mental health and public health. We are bipartisan. We are medical doctors, lawmakers, treatment providers, preventionists, teachers, law enforcement officers and others who seek a middle road between incarceration and legalization. Our commonsense, third-way approach to marijuana policy is based on reputable science and sound principles of public health and safety.

Copyright (C) 2025 The Drug Report. All rights reserved.
You are receiving this email because you opted in at our website, gooddrugpolicy.org or through the Smart Approaches to Marijuana website, learnaboutsam.org.
Our mailing address is:
The Drug Report 107 S West St Ste. 757 Alexandria, VA 22314 USA

Want to change how you receive these emails?
You can update your preferences ([link removed][UNIQID]&c=65f7be511c) or unsubscribe ([link removed][UNIQID]&c=65f7be511c)

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Smart Approaches to Marijuana (SAM) . 107 S West St. Ste. 757 . Alexandria, VA 22314 . USA